Abbott India Limited Share Price

Equities

ABBOTINDIA

INE358A01014

Pharmaceuticals

Market Closed - Bombay S.E. 11:00:50 26/04/2024 BST 5-day change 1st Jan Change
25,865 INR +0.78% Intraday chart for Abbott India Limited -1.02% +13.18%

Financials

Sales 2024 * 58.91B 707M 56.56B Sales 2025 * 65.79B 789M 63.17B Capitalization 550B 6.59B 528B
Net income 2024 * 11.88B 142M 11.4B Net income 2025 * 13.45B 161M 12.91B EV / Sales 2024 * 8.94 x
Net cash position 2024 * 22.66B 272M 21.76B Net cash position 2025 * 26.6B 319M 25.54B EV / Sales 2025 * 7.95 x
P/E ratio 2024 *
46.1 x
P/E ratio 2025 *
40.6 x
Employees 3,700
Yield 2024 *
1.13%
Yield 2025 *
1.3%
Free-Float 24.52%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.78%
1 week-1.02%
Current month-4.01%
1 month-3.30%
3 months+3.25%
6 months+14.26%
Current year+13.18%
More quotes
1 week
25 200.05
Extreme 25200.05
26 550.00
1 month
25 200.05
Extreme 25200.05
27 704.05
Current year
22 750.50
Extreme 22750.5
29 628.15
1 year
20 594.25
Extreme 20594.25
29 628.15
3 years
14 865.00
Extreme 14865
29 628.15
5 years
7 150.00
Extreme 7150
29 628.15
10 years
1 705.00
Extreme 1705
29 628.15
More quotes
Managers TitleAgeSince
Chief Executive Officer - 31/12/94
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 68 31/03/19
Chairman 81 31/12/67
Director/Board Member 67 31/12/95
More insiders
Date Price Change Volume
26/04/24 25,865 +0.78% 269
25/04/24 25,664 +0.79% 521
24/04/24 25,462 -1.10% 815
23/04/24 25,744 -1.97% 620
22/04/24 26,261 +0.50% 548

Delayed Quote Bombay S.E., April 26, 2024 at 11:00 am

More quotes
Abbott India Limited is an India-based company that is engaged in the pharmaceuticals business. The Company has a portfolio of offerings in diagnostics, medical devices, nutrition products and branded generic medicines. It provides products and solutions across various therapeutic areas, such as women's health, gastroenterology, central nervous system, metabolic, multi-specialty, and vaccines, among others. Its products include Colospa (irritable bowel disease), Ganaton (gastrointestinal motility), Librax (irritable bowel disease), Zolfresh (insomnia), Thyronorm (hypothyroidism), Duphaston (miscarriage and IVF), Duphalac (constipation), Digene (antacid), Prothiaden (pain and depression), Influvac (prevention of influenza), Creon (pancreatic insufficiency), Cremaffin Plus (Constipation), Pankreoflat (indigestion), Brufen P (fever), Duvadilan (preterm labor), and others. It offers various products under brands, such as Similac, PediaSure, Pedialyte, EleCare, Ensure, Glucerna, and others.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock